TAFINLAR

Опис товару

About TAFINLAR

TAFINLAR is a prescription medication containing the active ingredient Dabrafenib (Dabrafenib Mesylate), a kinase inhibitor used in the treatment of certain types of cancer. It is specifically indicated for the treatment of unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, and for the treatment of anaplastic thyroid cancer with a BRAF V600E mutation.

Key Benefits & Uses

• Treatment of unresectable or metastatic melanoma with a BRAF V600E or V600K mutation
• Treatment of anaplastic thyroid cancer with a BRAF V600E mutation
• Targeted therapy for BRAF V600E or V600K mutated cancers

Active Ingredient & Action

Dabrafenib (Dabrafenib Mesylate) works by inhibiting the activity of the BRAF protein, a key enzyme involved in the development and progression of certain types of cancer. By blocking the activity of BRAF, Dabrafenib helps to slow or stop the growth of cancer cells.

Important Notes

TAFINLAR should only be used under the guidance of a qualified healthcare professional. Patients should be aware of the potential side effects, including skin rash, fever, and fatigue. Regular monitoring of liver function and skin health is recommended during treatment with TAFINLAR.